Gender differences in the efficacy of pioglitazone treatment in nonalcoholic fatty liver disease patients with abnormal glucose metabolism
ConclusionThe study recommends pioglitazone plus lifestyle intervention for Chinese NAFLD female patients with abnormal glucose metabolism.Trial registrationRole of Pioglitazone and Berberine in Treatment of Non-Alcoholic Fatty Liver Disease,NCT00633282. Registered on 3 March 2008,https://register.clinicaltrials.gov.
Source: Biology of Sex Differences - Category: Biology Source Type: research
More News: Actos | Alcoholism | Biology | China Health | Clinical Trials | Diabetes | Diabetes Type 2 | Endocrinology | Fatty Liver Disease (FLD) | Liver | Liver Disease | Non-alcoholic Fatty Liver Diseases (NAFLD) | Smokers | Study | Urology & Nephrology | Women